Compare Pfizer with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DR. REDDYS LAB - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DR. REDDYS LAB PFIZER/
DR. REDDYS LAB
 
P/E (TTM) x 48.8 40.2 121.4% View Chart
P/BV x 8.1 5.5 147.4% View Chart
Dividend Yield % 0.4 0.5 87.3%  

Financials

 PFIZER   DR. REDDYS LAB
EQUITY SHARE DATA
    PFIZER
Mar-19
DR. REDDYS LAB
Mar-20
PFIZER/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,8403,363 114.2%   
Low Rs2,0802,352 88.4%   
Sales per share (Unadj.) Rs455.01,054.2 43.2%  
Earnings per share (Unadj.) Rs93.8121.9 76.9%  
Cash flow per share (Unadj.) Rs109.4190.2 57.5%  
Dividends per share (Unadj.) Rs22.5025.00 90.0%  
Dividend yield (eoy) %0.80.9 86.9%  
Book value per share (Unadj.) Rs658.2938.7 70.1%  
Shares outstanding (eoy) m45.75166.17 27.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.52.7 240.0%   
Avg P/E ratio x31.623.4 134.7%  
P/CF ratio (eoy) x27.115.0 180.1%  
Price / Book Value ratio x4.53.0 147.7%  
Dividend payout %24.020.5 117.0%   
Avg Mkt Cap Rs m135,420474,831 28.5%   
No. of employees `0002.621.7 12.2%   
Total wages/salary Rs m3,23833,802 9.6%   
Avg. sales/employee Rs Th7,911.48,091.0 97.8%   
Avg. wages/employee Rs Th1,230.91,561.3 78.8%   
Avg. net profit/employee Rs Th1,630.7935.8 174.3%   
INCOME DATA
Net Sales Rs m20,815175,170 11.9%  
Other income Rs m1,6746,206 27.0%   
Total revenues Rs m22,489181,376 12.4%   
Gross profit Rs m5,71224,421 23.4%  
Depreciation Rs m71411,348 6.3%   
Interest Rs m73983 7.4%   
Profit before tax Rs m6,59918,296 36.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309-1,403 -164.5%   
Profit after tax Rs m4,29120,260 21.2%  
Gross profit margin %27.413.9 196.8%  
Effective tax rate %35.0-7.7 -456.2%   
Net profit margin %20.611.6 178.2%  
BALANCE SHEET DATA
Current assets Rs m27,167125,991 21.6%   
Current liabilities Rs m8,91772,141 12.4%   
Net working cap to sales %87.730.7 285.2%  
Current ratio x3.01.7 174.4%  
Inventory Days Days6873 92.8%  
Debtors Days Days30105 28.7%  
Net fixed assets Rs m8,86283,854 10.6%   
Share capital Rs m458831 55.1%   
"Free" reserves Rs m29,656155,157 19.1%   
Net worth Rs m30,113155,988 19.3%   
Long term debt Rs m251,304 1.9%   
Total assets Rs m39,400232,253 17.0%  
Interest coverage x91.519.6 466.7%   
Debt to equity ratio x00 9.9%  
Sales to assets ratio x0.50.8 70.0%   
Return on assets %11.19.1 121.1%  
Return on equity %14.213.0 109.7%  
Return on capital %22.112.6 175.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42884,193 0.5%   
Fx outflow Rs m78639,616 2.0%   
Net fx Rs m-35844,577 -0.8%   
CASH FLOW
From Operations Rs m97829,841 3.3%  
From Investments Rs m351-4,923 -7.1%  
From Financial Activity Rs m-1,099-25,159 4.4%  
Net Cashflow Rs m231-266 -86.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 4.9 35.3 13.9%  
ADR/GDR % 0.0 18.5 -  
Free float % 23.7 15.3 154.9%  
Shareholders   85,207 75,885 112.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Tata Consumer March Quarter Results, M&M's Advanced Design Centre, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended higher on Friday. Benchmark indices edged higher tracking gains in index majors HDFC twins and positive cues from global markets.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 7, 2021 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS